Washington State University Startup to be Showcased by the Michael J. Fox Foundation

M3 Biotechnology, a Washington State University startup, was selected as one of five companies to be showcased by the Michael J. Fox Foundation (MJFF) for their work on neurodegenerative disease therapies. The MJFF aims to accelerate the research and development of projects in Parkinson’s disease research by making the researchers and projects more visible.

M3 Biotechnologies has been chosen by the MJFF to push the MM-201 development, their oral drug designed to reverse the neurodegenerative effects of Parkinson’s disease.

Visit http://commercialization.wsu.edu for more information.